Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort
about
Gastric cancer: descriptive epidemiology, risk factors, screening, and preventionEtiology and Prevention of Gastric CancerManagement of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade PortuEvaluation of routine biopsies in endoscopic screening for esophagogastric junction cancer.Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach.Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study.Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis.Pepsinogen I and II, Gastrin and Cag A Serum Levels in ShirazSerological assessment of gastric mucosal atrophy in gastric cancer.The role of serum pepsinogen in the detection of gastric cancerSerum thyroglobulin, a biomarker for iodine deficiency, is not associated with increased risk of upper gastrointestinal cancers in a large Chinese cohort.Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort.Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas.The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas.Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancerReduction of apoptosis by proanthocyanidin-induced autophagy in the human gastric cancer cell line MGC-803.Gastric atrophy and oesophageal squamous cell carcinoma: possible interaction with dental health and oral hygiene habitClinicopathological characterisation of small (2 cm or less) proximal and distal gastric carcinomas in a Chinese population.Serum pepsinogen II is a better diagnostic marker in gastric cancer.Serum prohepcidin levels are lower in patients with atrophic gastritis.Atrophic gastritis: risk factor for esophageal squamous cell carcinoma in a Latin-American populationAssociation between the expression levels of tumor necrosis factor-α-induced protein 8 and the prognosis of patients with gastric adenocarcinomaPrediagnostic plasma vitamin C and risk of gastric adenocarcinoma and esophageal squamous cell carcinoma in a Chinese populationHow to assess the severity of atrophic gastritisA Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.Serum pepsinogens in gastric cancer screening.Serum pepsinogen reference intervals in apparently healthy Chinese population with latex enhanced turbidimetric immunoassay.Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.Age-Specific Gastric Cancer Risk Indicated by the Combination of Helicobacter pylori Sero-Status and Serum Pepsinogen Levels.Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portug
P2860
Q26849435-89C0AAF7-7F30-4BE4-A1A7-51CFBA8FA1E3Q28072819-FED804DB-D225-4A7E-90BC-35704E6F612FQ30426539-2FF5B73E-C5A5-4F1D-8B5D-F4D2DA0DFB88Q33564217-EB72E5F7-78C4-47A1-8390-47663E233E01Q33573713-73109E4A-07A3-45B4-A257-EBA55218A310Q34058039-D9B8109A-EFCC-44CB-A85A-1FF679592380Q34069642-0025A261-B1EE-471F-88D6-0AEC11E35415Q34134987-B5340F71-529E-4DA2-BE6C-4DF19B3AB1F3Q34145097-5D5BBDA4-49EC-48D3-9906-E9701DEC95DAQ34206645-069A4F10-F146-46A3-B111-B71274D4D956Q34785839-D43F1AEE-71A5-412A-A6D5-8C730AB7FFDFQ35006927-F3B3C715-0894-42DA-BFE9-9AC325014605Q35067345-0007E849-2DA7-4B82-98CC-860FBF02B29EQ35115249-80192513-1660-45ED-ADA2-F5E849852FEFQ35261353-82AE56B4-D2A9-4D98-BD91-5393CC4EFBB9Q35842490-A11BC189-10D2-4758-B87B-2C0D879B90EDQ36184216-17BA3F6E-7360-4978-8697-8EB6E6ABDBC2Q36424771-5C862651-C0EF-4B61-86D3-9894BB057002Q36529253-18122830-0723-4682-8001-F278CA4AFD61Q36702756-6F126A3D-35BD-43CA-9E00-2E053BB9CDEAQ36759219-B5058AAC-1EC8-4988-9AAC-AADBFCCF1374Q37001794-68F1C7B4-41E2-4A95-8654-D43B63ABF693Q37233186-C690A3AA-5DAA-4DF4-8623-F9AD9C9A8A31Q37864082-3DDAFD88-03BB-4AFE-A5FD-B1C6F2150E3CQ40282956-3D26A6B1-B3FD-4A58-8087-EA3C6ED73435Q42839640-DC6D1E6C-FF7E-419E-9B30-E641CF82A372Q43452551-D3F6D93B-1A4E-4265-AFB5-6CA1DBFE0B29Q48111399-7494F215-49C5-4323-AED5-AF33F202CF74Q54858925-20854FB6-27DD-4AEF-A44B-BD8BC89A0D83Q57698678-692A8A3E-2669-49DB-AFED-558EF429254C
P2860
Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum pepsinogens and risk of ...... tion Intervention Trial cohort
@en
Serum pepsinogens and risk of ...... ion Intervention Trial cohort.
@nl
type
label
Serum pepsinogens and risk of ...... tion Intervention Trial cohort
@en
Serum pepsinogens and risk of ...... ion Intervention Trial cohort.
@nl
prefLabel
Serum pepsinogens and risk of ...... tion Intervention Trial cohort
@en
Serum pepsinogens and risk of ...... ion Intervention Trial cohort.
@nl
P2093
P2860
P356
P1433
P1476
Serum pepsinogens and risk of ...... tion Intervention Trial cohort
@en
P2093
F Kamangar
P R Taylor
S M Dawsey
P2860
P304
P356
10.1136/GUT.2008.168641
P407
P577
2009-01-09T00:00:00Z